Molecule intelOpportunity: Lower0

Potassium Nitrate

10 brands · 8 companies · product forms

2 DRAP alerts

Opportunity snapshot

Launch attractiveness
14
Market saturation
21
Price room
0
Regulatory risk
60
10
brands
8
companies
Rs 6,736.39
median price
1
price points
1x
price spread
65
confidence %

Who competes here

Top companies by brand count · leader share 20%

Price room

Across observed sources and strengths
CheapestRs 6,736.39
MedianRs 6,736.39
Most expensiveRs 6,736.39
Spread1×
Sources: DVAGO

Only 1 trusted price points; variation not scored (low data).

Regulatory alerts

latest 2022-06-16
Suspension of Drug Registration: Famotidine Liquid Suspension in the Strengths of 10mg/5mL
Suspension of Drug Registration: Tablets of Diclofenac Potassium in Strengths of 75mg and

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(0) + 20% low-competition(79) + 15% supply-disruption(0), damped by confidence(65). Higher = more attractive, less crowded opportunity.

Market saturation

8 canonical companies and 10 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

Only 1 trusted price points; variation not scored (low data).

Regulatory risk

2 DRAP alert(s), latest 2022-06-16.

Confidence

Reduced by: sparse price data, no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.